Bringing Regulatory-Style Benefit-Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for...

Area of Science:

• Medical Evidence Synthesis
• Clinical Decision Science
• Value-Based Healthcare

Background:

• Current clinical summaries fragment efficacy and safety data, obscuring absolute effects and patient variability.
• Existing methods fail to integrate individual patient preferences into treatment evaluations.
• Point-of-care summaries lack transparency in benefit-risk assessments.

Purpose of the Study:

• To introduce a structured evidence synthesis method for clinician-facing summaries.
• To translate complex benefit-risk evaluation logic into a format supporting shared decision-making.
• To enhance the integration of patient values into clinical treatment choices.

Main Methods:

• Developed a seven-domain value structure based on benefit-risk assessment (BRAT, MCDA) and decision science.
• Created a workflow featuring an effects table presenting absolute benefits and harms per 1000 patients.
• Introduced Net Clinical Benefit (NCB) and Trade-off Index (TIX) summary metrics.

Main Results:

• Presented a novel framework for benefit-risk summary and compared it to existing approaches.
• Outlined a development pathway including standardization, pilot testing, and evaluation.
• Demonstrated a method to make multi-outcome trade-offs explicit and testable.

Conclusions:

• The proposed methodology connects benefit-risk evaluation with clinical dialogue by clarifying trade-offs.
• The framework facilitates bedside discussions, integrating patient priorities into treatment decisions.
• Further empirical research is needed to confirm improved alignment between treatment choices and patient values.